Matthew Schneier

features writer for New York Magazine and The Cut covering culture, style, and the city

Matthew Schneier on KCRW

The drug Ozempic has become an appetite suppressant for some rich and well-connected people. It's changing the definition of thinness and what it takes to achieve it.

Latest weight-loss craze is a drug for diabetics — Ozempic

The drug Ozempic has become an appetite suppressant for some rich and well-connected people. It's changing the definition of thinness and what it takes to achieve it.

from Press Play with Madeleine Brand

More from KCRW

We may still have some lingering pandemic fatigue but the new bird flu has the potential for significant harm if we are not careful.

from Second Opinion

Out-of-pocket costs for Paxlovid have shot up for Medicare patients, and programs to help get the COVID-alleviating drug for less aren’t well known.

from KCRW Features

How should the media cover a Biden/Trump rematch? What mistakes did we see in coverage of the special counsel testimony? Should perception influence policy?

from Left, Right & Center

Surviving in the mountainous rainforests of Uganda.

from Second Opinion

On this episode of the Scheer Intelligence podcast, host Robert Scheer welcomes Maxwell L.

from Scheer Intelligence

Institutional Care for People with Neurodiversity

from Second Opinion

How to deal with sex and chronic pain? When to bring up a mental health condition in a relationship? And the best and worst parts of dating with a disability.

from How’s Your Sex Life?

Poet and essayist Ross Gay shares stories of joy and theorizes that the experience of joy might possibly be the best tool for uniting and depolarizing us as a people.

from Life Examined

Is there anything about Trump’s abortion position for Joe Biden to capitalize on? Will Biden’s change of tune on Israel win him more supporters?

from Left, Right & Center